| Structure | Chemical Name | CAS | MF |
|
BACOPASAPONIN C
|
178064-13-6
|
C46H74O17
|
|
NALPHA-(5-FLUORO-2,4-DINITROPHENYL)-L-LEUCINAMIDE
|
178065-29-7
|
C12H15FN4O5
|
|
NALPHA-(5-FLUORO-2,4-DINITROPHENYL)-D-LEUCINAMIDE
|
178065-30-0
|
C12H15FN4O5
|
|
5,8-Methano-1,7-naphthyridine(9CI)
|
178094-95-6
|
C9H6N2
|
|
Arg-binding protein 1
|
178097-36-4
|
|
|
L-[1-13C]XYLOSE
|
178101-87-6
|
C5H10O5
|
|
L-Threoascorbic acid-1-13C
|
178101-88-7
|
C6H8O6
|
|
L-Ascorbic Acid-2-13C
|
178101-89-8
|
C6H8O6
|
|
Methyl 4-(1-hydroxyprop-2-ynyl)benzoate
|
178110-08-2
|
C11H10O3
|
|
Pyridine, 3-(3-silylpropyl)- (9CI)
|
178110-88-8
|
C8H13NSi
|
|
Bicyclo[2.2.1]heptan-2-ol, 5-amino-, (1R,2S,4R,5S)-rel- (9CI)
|
178111-37-0
|
C7H13NO
|
|
Fmoc-D-4-Hydroxyphenylglycine
|
178119-93-2
|
C23H19NO5
|
|
FMOC-5-HYDROXY-L-TRYPTOPHAN
|
178119-94-3
|
C26H22N2O5
|
|
Erinacine F
Erinacin F
|
178120-47-3
|
C25H36O6
|
|
Carbamic acid, [(1R,4S)-4-hydroxy-2-cyclopenten-1-yl]-, 1,1-dimethylethyl
|
178152-48-2
|
C10H17NO3
|
|
2(1H)-Quinoxalinone,3,4-dihydro-3-(hydroxymethyl)-,(S)-(9CI)
|
178153-01-0
|
C9H10N2O2
|
|
ETHYL 5-NITRO-3-OXO-2,3-DIHYDRO-1H-INDAZOLE-1-CARBOXYLATE
|
178160-22-0
|
C10H9N3O5
|
|
1,5-Cyclohexadiene-1-carboxaldehyde, 3,3,5-trimethyl- (9CI)
|
178160-84-4
|
C10H14O
|
|
1-Cyclohexene-1-carboxaldehyde, 5,5-dimethyl-3-methylene- (9CI)
|
178160-85-5
|
C10H14O
|
|
1,3-Cyclohexadiene-1-carboxaldehyde, 3,5,5-trimethyl- (9CI)
|
178160-87-7
|
C10H14O
|
|
2,7-BIS(TERT-BUTYLDIMETHYLSILANYLOXY)NAPHTHALENE
|
178161-06-3
|
C22H36O2Si2
|
|
1-(4-BROMO-BENZYL)-PIPERIDINE
|
178162-69-1
|
C12H16BrN
|
|
2-(3,4-dichlorophenyl)-2-pyrrolidin-1-ylethanamine
|
178167-17-4
|
C12H16Cl2N2
|
|
2,7,8-TRIMETHYL-2-(BETA-CARBOXY-ETHYL)-6-HYDROXYCHROMAN
|
178167-75-4
|
C15H20O4
|
|
3-(2,7,8-trimethyl-chroman-2-yl)-propionic acid
|
178167-77-6
|
C15H20O3
|
|
3-Isoxazoleacetic acid, 5-hydroxy- (9CI)
|
178168-21-3
|
C5H5NO4
|
|
Benzoic acid, 3-[(cyanoacetyl)amino]- (9CI)
|
178168-23-5
|
C10H8N2O3
|
|
tert-Butyl 2,3,4,5-tetrahydro-1H-azepine-1-carboxylate
|
178172-25-3
|
C11H19NO2
|
|
(S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester
|
178172-26-4
|
C12H19NO4
|
|
1,1-dimethylethyl ester3,4-dihydro-5-methyl-1(2H)-Pyridinecarboxylic acid
|
178172-28-6
|
C11H19NO2
|
|
1,3-Dioxane,5-methoxy-2-(1-methylethyl)-(9CI)
|
178173-49-4
|
C8H16O3
|
|
3-Butyn-2-ol, 4-(2-furanyl)-2-methyl- (9CI)
|
178173-83-6
|
C9H10O2
|
|
7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-5-methyl-4 -oxo-quinoline-3-carboxylic acid hydrochloride
|
178173-90-5
|
C19H23ClFN3O4
|
|
7-((S)-3-Amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-hy droxy-4-oxoquinoline-3-carboxylic acid
|
178174-16-8
|
|
|
7-((S)-3-Amino-1-pyrrolidinyl)-8-ethoxy-1-cyclopropyl-6-fluoro-1,4-dih ydro-4-oxoquinoline-3-carboxylic acid hydrochloride
|
178174-17-9
|
|
|
7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-8-(difluoromethoxy)-6-fluoro- 5-methyl-4-oxo-quinoline-3-carboxylic acid
|
178174-19-1
|
C19H20F3N3O4
|
|
9H-Carbazole-9-ethanol, 1,2,3,4-tetrahydro-
|
178174-35-1
|
C14H17NO
|
|
Methyl 2-diphenylphosphino-1-n
|
178176-78-8
|
C24H19O2P
|
|
2-DIPHENYLPHOSPHINO-1-NAPHTHOIC ACID
|
178176-80-2
|
C23H17O2P
|
|
(RAC)-ETHYLENEBIS(4,5,6,7-TETRAHYDRO-1-INDENYL)DIFLUOROTITANIUM(IV)
|
178177-04-3
|
C20H24F2Ti
|
|
4-nitrophenyl 2-fluoropropionate
|
178181-33-4
|
C9H8FNO4
|
|
Alanine, N-(2-fluoro-1-oxopropoxy)alanyl- (9CI)
|
178181-39-0
|
C9H15FN2O5
|
|
Carbamic acid, (3-fluoropropyl)-, 1,1-dimethylethyl ester (9CI)
|
178181-51-6
|
C8H16FNO2
|
|
Carbamic acid, (2-fluoroethyl)-, 1,1-dimethylethyl ester (9CI)
|
178181-52-7
|
C7H14FNO2
|
|
tert-butyl 4-fluoropiperidine-1-carboxylate
|
178181-55-0
|
C10H18FNO2
|
|
Piperidine, 1-(2-fluoro-1-oxopropyl)- (9CI)
|
178181-56-1
|
C8H14FNO
|
|
isonicotinamide
|
178183-25-0
|
C6H6N2O
|
|
3-Pyridinemethanesulfonic acid, 5,5-1,4-phenylenebisimino(6-fluoro-1,3,5-triazine-4,2-diyl)imino(6-sulfo-3,1-phenylene)azobis1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-, sodium salt
|
178198-11-3
|
C42H41F2N16NaO16S4
|
|
(S)-4-ACETYLOXY-MANDELONITRILE
|
178201-08-6
|
C10H9NO3
|
|
1H-INDOLE-1-CARBOXYLIC ACID,2,3-DIHYDRO-6-HYDROXY-,PHENYLMETHYL ESTER
|
178201-65-5
|
C16H15NO3
|
|
2-METHYLSULFONYL-5-TRIFLUOROMETHYLPYRIDINE
|
178204-50-7
|
C7H6F3NO2S
|
|
1H-Pyrrole-2-acetonitrile, 1-acetyl-2,5-dihydro-, (R)- (9CI)
|
178206-94-5
|
C8H10N2O
|
|
1H-Pyrrole, 1-acetyl-2,5-dihydro-2-(2-oxopropyl)-, (R)- (9CI)
|
178206-95-6
|
C9H13NO2
|
|
BOC-N-ME-D-TYR-OH DCHA
|
178208-61-2
|
C15H21NO5
|
|
6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-3-aMine
|
178209-28-4
|
C10H14N2
|
|
5H-Cyclopenta[b]pyridin-3-amine,6,7-dihydro-(9CI)
|
178209-29-5
|
C8H10N2
|
|
ALLYL 4-BROMOBUTYRATE
|
178215-45-7
|
C7H11BrO2
|
|
Pentanethioamide, N,N-dimethyl-3-oxo-
|
178218-29-6
|
C7H13NOS
|
|
4H-Azepin-4-one, hexahydro-1-methyl-2-thioxo-
|
178218-30-9
|
C7H11NOS
|
|
3-Benzylamino-1,1,1-trifluoro-propan-2-ol
|
178218-36-5
|
C10H12F3NO
|
|
Quinoxaline, 2-(ethenyloxy)-
|
178218-46-7
|
C10H8N2O
|
|
Calystegine B3
|
178231-95-3
|
C7H13NO4
|
|
Erinacine E
Erinacin E
|
178232-25-2
|
C25H36O6
|
|
7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-6,8-difluoro-5-methyl-4-oxo-q uinoline-3-carboxylic acid
|
178233-18-6
|
C18H19F2N3O3
|
|
4-ISOPROPYL-4'-METHYLDIPHENYLIODONIUM TETRAKIS(PENTAFLUOROPHENYL)BORATE
|
178233-72-2
|
C40H18BF20I
|
|
|
ACETYLKITASAMYCIN
|
178234-32-7
|
C41H64NO16R
|
|
7-Azabicyclo[2.2.1]heptane-2-carboxylicacid,methylester,(1R,2R,4S)-rel-
|
178241-05-9
|
C8H13NO2
|
|
(1-AMINO-CYCLOHEXYL)-ACETIC ACID METHYL ESTER
|
178242-64-3
|
C9H17NO2
|
|
methyl 2-(1-aminocyclopentyl)acetate
|
178242-71-2
|
C8H15NO2
|
|
Cyclopentaneacetic acid, 1-(dimethylamino)-, methyl ester (9CI)
|
178242-72-3
|
C10H19NO2
|
|
7-Oxa-1-azaspiro[3.5]nonan-2-one
|
178242-92-7
|
C7H11NO2
|
|
4-AMINO-TETRAHYDROPYRAN-4-ACETIC ACID METHYL ESTER
|
178242-93-8
|
C8H15NO3
|
|
2-(TETRAHYDRO-2H-THIOPYRAN-4-YL)ACETAMIDE
|
178243-07-7
|
C7H13NOS
|
|
MAGE-3 ANTIGEN (167-176) (HUMAN)
|
178243-46-4
|
C53H80N12O16S
|
|
Cyclohexane, 2-ethynyl-4-methyl-1-(1-methylethyl)-, (1S,2R,4R)- (9CI)
|
178243-92-0
|
C12H20
|
|
N-ACETYL-N-(2-ISOPROPYL-4-OXO-3(4H)-QUI&
|
178244-37-6
|
C15H17N3O3
|
|
Acetamide, N-[2-(1-piperazinyl)ethyl]- (9CI)
|
178244-38-7
|
C8H17N3O
|
|
Oxiranecarboxylic acid, 3-cyclopropyl-, methyl ester, (2R,3R)- (9CI)
|
178248-34-5
|
C7H10O3
|
|
Oxiranecarboxylic acid, 3-cyclopropyl-, ethyl ester, (2R-cis)- (9CI)
|
178248-36-7
|
C8H12O3
|
|
Orphanin FQ (1-11)
|
178249-41-7
|
C49H75N15O14
|
|
NOCICEPTIN (1-7)
|
178249-42-8
|
C31H41N7O9
|
|
|
PEG-20 HEXADECENYLSUCCINATE
|
178254-04-1
|
|
|
1-(methylsulfonyl)spiro[indoline-3,4'-piperidine]
|
178261-41-1
|
C13H18N2O2S
|
|
N-[6-[Bis(4-Methoxyphenyl)phenylMethoxy]hexyl]-2,2,2-trifluoro-acetaMide
|
178261-42-2
|
C29H32F3NO4
|
|
[6-[Bis(4-Methoxyphenyl)phenylMethoxy]hexyl]-carbaMic Acid 2-[(2-Hydroxyethyl)sulfonyl]ethyl Ester
|
178261-44-4
|
C32H41NO8S
|
|
Butanedioic Acid Mono[16,16-bis(4-Methoxyphenyl)-3,3-dioxido-7-oxo-16-phenyl-6,15-dioxa-3-thia-8-azahexadec-1-yl] Ester
|
178261-45-5
|
C36H45NO11S
|
|
1-(4-BROMOPHENYL)-3-(DIMETHYLAMINO)-2-BUTEN-1-ONE
|
178261-64-8
|
C12H14BrNO
|
|
6-Nitro-3-chromanone
|
178262-27-6
|
C9H7NO4
|
|
METHYL ISOQUINOLINE-7-CARBOXYLATE
|
178262-31-2
|
C11H9NO2
|
|
ethyl 6-(bromomethyl)pyridine-3-carboxylate
|
178264-57-8
|
C9H10BrNO2
|
|
4'-(4-AMINOPHENYL)-2,2':6',2''-TERPYRIDINE
|
178265-65-1
|
C21H16N4
|
|
N-Benzyl-6-Methyl-1H-pyrrolo[3,2-c]pyridin-4-aMine
|
178268-87-6
|
C15H15N3
|
|
4H-Pyrrolo[3,2-c]pyridin-4-one,1,5-dihydro-6-methyl-(9CI)
|
178268-91-2
|
C8H8N2O
|
|
1H-Pyrrolo[3,2-c]pyridine, 4-chloro-6-Methyl-
|
178268-92-3
|
C8H7ClN2
|
|
1H-Pyrrolo[2,3-b]pyridine,6-methyl-,7-oxide(9CI)
|
178268-96-7
|
C8H8N2O
|
|
1H-Pyrrolo[2,3-b]pyridine, 6-methyl-4-nitro-
|
178268-98-9
|
C8H7N3O2
|
|
1H-Pyrrolo[2,3-b]pyridine, 6-methyl-3-nitro-
|
178269-03-9
|
C8H7N3O2
|
|
Dicyanobis(1,10-phenanthroline)iron(II)
|
178269-09-5
|
C26H16FeN6
|
|
Duloxetine N-DesMethyl Metabolite
|
178273-35-3
|
C17H17NOS
|
|
5-hydroxy-2-iodotyrosine
|
178273-55-7
|
|